Strategies That Support Declining Cholinergic Neurotransmission in Alzheimer’s Disease Patients

Publisher： Karger

E-ISSN： 1423-0003|45|1|3-14

ISSN： 0304-324x

Source： Gerontology, Vol.45, Iss.1, 1999-01, pp. : 3-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Magnesium and Alzheimer’s Disease: The Cholinergic Hypothesis

By  

Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine, Vol. 24, Iss. 6, 2012-11 ,pp. : 371-374

Karger

Access to resources Recommend Favorite

Neuropsychiatric Symptoms and Cholinergic Therapy for Alzheimer’s Disease

By  

Gerontology, Vol. 45, Iss. 1, 1999-01 ,pp. : 15-22

Karger

Access to resources Recommend Favorite

Inflammation and Anti-Inflammatory Strategies for Alzheimer’s Disease – A Mini-Review

By  

Gerontology, Vol. 56, Iss. 1, 2009-09 ,pp. : 3-14

Karger

Access to resources Recommend Favorite

Pain and Alzheimer’s Disease

By  

Gerontology, Vol. 46, Iss. 5, 2000-08 ,pp. : 235-241

Karger

Access to resources Recommend Favorite

Somatotype in Alzheimer’s Disease

By  

Gerontology, Vol. 53, Iss. 4, 2007-03 ,pp. : 200-204

Karger

Access to resources Recommend Favorite